1
|
Gelmetti C, Rigoni C, Cantù AM, Agolzer A, Agrusa A, Brena M, Dall'Oglio F, Demichelis P, Farina S, Frasin LA, Lorenzi S, Mazzola G, Praticò M, Robotti S, Tedeschi A, Villa L, Ananiadis P, Arkoumani E, Astashonok I, Baselga Torres E, Borici S, Cano E, Cela R, Cengo A, Corella F, Cubiro Raventos X, De Jesus Silva MA, Demiraj E, Dhima E, Doci X, Domarad A, Didyk M, Dyli A, Efthimiou O, Filippi G, Flores Climente VA, Garcia Muret MP, Navarro JG, Gega M, Giakoub AN, Giakoubis V, Gica A, Gjomema M, Guri B, Janushaj E, Kanelleas A, Kanelopoulou G, Kapaj E, Kapoukranidou D, Karadima K, Katsavou A, Kotrulja L, Kyriakou A, Larios G, Lopez A, Lopez C, Manoli SM, Matvienko T, Mervic L, Mileounis K, Muja D, Nadezhda M, Panagioti D, Papakonstantis M, Papanikou M, Papathemeli D, Papigkioti K, Pivak V, Preza D, Roé E, Rogl Butina M, Serra Baldrich E, Sgouros D, Shilova A, Shllaku E, Sideris N, Sina E, Sinani A, Sourli-Chasioti F, Stankaj M, Tasioula D, Tsalmadoupis A, Tsatsou F, Tsenebi E, Tsitlakidou A, Vassis P, Vilarrassa E, Vorobey O, Voutsakis N, Yakovleva S, Yakubovskaya S, Yerygina E, Zarras A, Zenelaj V, Zenko O. Topical prebiotics/postbiotics and PRURISCORE validation in atopic dermatitis. International study of 396 patients. J DERMATOL TREAT 2023; 34:2131703. [PMID: 36205596 DOI: 10.1080/09546634.2022.2131703] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Aim: To investigate the efficacy and tolerability of a cream (Rilastil Xerolact PB) containing a mixture of prebiotics and postbiotics, and to validate the PRURISCORE itch scale in the management of atopic dermatitis.Methods: The study is based on 396 subjects of both sexes in three age groups (i.e., infants, children, adults) suffering from mild/moderate Atopic Dermatitis, recruited from 8 European countries and followed for 3 months.Results: The product demonstrated good efficacy combined with good/very good tolerability in all age groups. In particular, SCORAD, PRURISCORE and IGA scores decreased significantly over the course of the study. The PRURISCORE was preferred to VAS by the vast majority of patients.Conclusion: Even though the role of prebiotics and postbiotics was not formally demonstrated since these substances were part of a complex formulation, it can be reasonably stated that prebiotics and postbiotics have safety and standardization features that probiotics do not have. In addition they are authorized by regulatory authorities, whereas topical probiotics are not.
Collapse
Affiliation(s)
- Carlo Gelmetti
- Department of Dermatology, Fondazione IRCCS Ca' Granda "Ospedale Maggiore Policlinico", Università degli Studi di Milano, Milan, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | -
- Associazione DDI - Donne Dermatologhe, Napoli, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Nikopoulou VA, Holeva V, Parlapani E, Karamouzi P, Voitsidis P, Porfyri GN, Blekas A, Papigkioti K, Patsiala S, Diakogiannis I. Mental Health Screening for COVID-19: a Proposed Cutoff Score for the Greek Version of the Fear of COVID-19 Scale (FCV-19S). Int J Ment Health Addict 2020; 20:907-920. [PMID: 33199975 PMCID: PMC7654349 DOI: 10.1007/s11469-020-00414-w] [Citation(s) in RCA: 52] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 10/16/2020] [Indexed: 01/16/2023] Open
Abstract
The COVID-19 pandemic elicited fear. The Fear of COVID-19 Scale (FCV-19S) is a newly developed self-reported measure, originally developed in Persian to assess COVID-19-related fear. To date, the scale has been translated and validated in 19 other languages, among which Greek. This study, conducted through an online survey, aimed to further explore the validity of the Greek FCV-19S version, as well as to identify appropriate cutoff scores. A total of 538 respondents completed the sociodemographic data sheet, the Generalized Anxiety Disorder 7-item scale, the Short Health Anxiety Inventory, and the Posttraumatic Stress Disorder-8 inventory. According to the results, a cutoff point score of 16.5 or higher revealed a significant predictive power for anxiety, health anxiety, and posttraumatic stress symptoms. Altogether, although the cutoff scores of the Greek FCV-19S version were explored to further evaluate the scale’s validity, they may facilitate discrimination of adults with extreme COVID-19-related fear from those with normal fear reactions.
Collapse
Affiliation(s)
- V. A. Nikopoulou
- 1st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, General Hospital “Papageorgiou”, Ring Road Thessaloniki, N. Efkarpia, 54603 Thessaloniki, Greece
| | - V. Holeva
- 1st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, General Hospital “Papageorgiou”, Ring Road Thessaloniki, N. Efkarpia, 54603 Thessaloniki, Greece
| | - Eleni Parlapani
- 1st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, General Hospital “Papageorgiou”, Ring Road Thessaloniki, N. Efkarpia, 54603 Thessaloniki, Greece
| | - P. Karamouzi
- 1st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, General Hospital “Papageorgiou”, Ring Road Thessaloniki, N. Efkarpia, 54603 Thessaloniki, Greece
| | - P. Voitsidis
- 1st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, General Hospital “Papageorgiou”, Ring Road Thessaloniki, N. Efkarpia, 54603 Thessaloniki, Greece
| | - G. N. Porfyri
- 1st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, General Hospital “Papageorgiou”, Ring Road Thessaloniki, N. Efkarpia, 54603 Thessaloniki, Greece
| | - A. Blekas
- 1st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, General Hospital “Papageorgiou”, Ring Road Thessaloniki, N. Efkarpia, 54603 Thessaloniki, Greece
| | - K. Papigkioti
- 1st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, General Hospital “Papageorgiou”, Ring Road Thessaloniki, N. Efkarpia, 54603 Thessaloniki, Greece
| | - S. Patsiala
- 1st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, General Hospital “Papageorgiou”, Ring Road Thessaloniki, N. Efkarpia, 54603 Thessaloniki, Greece
| | - I. Diakogiannis
- 1st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, General Hospital “Papageorgiou”, Ring Road Thessaloniki, N. Efkarpia, 54603 Thessaloniki, Greece
| |
Collapse
|